Featured Insights

Malin Filler & Anita Annas

Learn about the Life Science Industry

Our featured insights contain all of our latest articles, columns and think pieces about issues that matter most in the life science industry today. 

Group
Real-World Evidence

What is Real World Evidence (RWE) and why do we need it?

It is has been long established that it is essential to conduct randomized controlled studies as part of the drug development process. However, these “high-level evidence” studies are not always sufficient to get approval from the regulatory bodies. Often, additional evidence from so-called “Real World Evidence” studies is required. Dr Robert Szulkin explains.
Group
Drug Development

You won´t find this many Concorde projects anywhere else

“The Concorde fallacy” has become known as a blatant example of what is called “sunk cost bias” in economic decision theory – we invest grandiosely and refuse for the longest time to see ourselves defeated. Why is it so common in drug development?
Group
Study Design

Studiedesign: Hur många patienter behövs i en klinisk studie?

Kan vi vara mer flexibla när vi gör studiedesign? Kan man modifiera studien när den pågår och man får mer information om effektstorlek och variabilitet?
Group
Stories

Using Statistics to Solve the Largest Mysteries

By using biostatistics and his expertise in research methodology, Niclas' wants to find a cure for Alzheimer's disease.
Group
Real-World Evidence

4 Crucial challenges in real-world evidence (RWE) studies

Planning and conducting a real-world evidence study can be very challenging. In this article, SDS consultant Robert Szulkin breaks down four crucial challenges when conducting an RWE study.

Group
Statistics

Prediktion och statistisk modellering under Covid-19 pandemin

Experterna på Aktuellt och i sjukvården använder ofta uttrycket ”modellering” i diskussioner runt hur covid-19-epidemin kommer att utveckla sig i Sverige och världen. Vad betyder egentligen ”statistisk modellering” – verkligheten är väl som den är och varför skall den då ”modelleras”?
Group
Regulatory Affairs

Regulatory affairs considerations for drug development

Why is it so important for Life Science companies to invest in regulatory affairs activities as part of the development program for their products? What are the challenges and the key aspects for regulatory and business success?
Group
Statistics

Statistikens atomer och molekyler

Statistikens minsta beståndsdelar är förstås data ch det allra enklaste vi kan beräkna är medelvärde, median, typvärde och range. Okej, ni vet redan vad det är? Då kan ni skippa den här artikeln, men inte förrän ni tvärsäkert analyserar problemet med min dotters matteprov...

Show more

 

 

SDS has joined Cytel

We are excited to share some big news! 🌟

SDS Life Science AB and SDS MedteQ AB are now a part of Cytel Inc, a leading global provider of statistical software and advanced analytics for clinical trial design and execution.   

Read more 

We use cookies to ensure that we give you the best experience on our website. Read our cookie policy here.